Visit the AndroGel® (testosterone gel) 1.62% CIII site, a prescription treatment for men with hypogonadism due to certain medical conditions.

Discover the different dosing levels of AndroGel® (testosterone gel) 1.62% and see the steps to inform patients about the proper application process.

AndroGel 1.62% is a topical testosterone replacement therapy gel available in a metered-dose pump or travel-ready packets. Before you begin treatment, there are a few things you should …

Learn answers to many common questions about hypogonadism, also known as low testosterone. Discover more about AndroGel® (testosterone gel) 1.62% CIII.

The recommended starting dose of AndroGel 1.62% is 40.5 mg. However, it’s important to schedule follow-ups to have your testosterone levels checked after starting treatment.

Helpful resources for healthcare providers to develop a successful treatment initiation plan for patients starting AndroGel® (testosterone gel) 1.62%.

The official AndroGel® (testosterone gel) 1.62% healthcare professional site from AbbVie Inc. Learn about the use, benefits, and risks of AndroGel.

AndroGel® (testosterone gel) 1% and 1.62% are controlled substances, available by prescription, used to treat adult males who have low or no testosterone due to certain medical conditions.

The potential for dermal testosterone transfer following AndroGel 1% use was evaluated in a clinical study between males dosed with AndroGel 1% and their untreated female partners.

AndroGel should be promptly discontinued until the cause of virilization is identified. Exposure of a pregnant woman to AndroGel may result in potential hazard to the fetus.